Published in PLoS Comput Biol on October 25, 2012
Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses. PLoS Pathog (2013) 0.97
Design requirements for interfering particles to maintain coadaptive stability with HIV-1. J Virol (2012) 0.94
Coadaptive stability of interfering particles with HIV-1 when there is an evolutionary conflict. J Virol (2013) 0.81
Virus wars: using one virus to block the spread of another. PeerJ (2016) 0.78
Reply to "Coadaptive stability of interfering particles with HIV-1 when there is an evolutionary conflict". J Virol (2013) 0.77
Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection. PLoS Comput Biol (2015) 0.77
Design and engineering of a transmissible antiviral defense. J Biol Eng (2016) 0.75
Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof Antivirals. PLoS Comput Biol (2016) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science (1989) 15.19
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (1995) 10.13
Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med (2002) 9.70
Defective viral particles and viral disease processes. Nature (1970) 7.24
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis (2011) 5.94
Adverse effects of antiretroviral therapy. Lancet (2000) 4.84
Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72
Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet (2002) 4.42
Recombination: Multiply infected spleen cells in HIV patients. Nature (2002) 4.38
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet (1999) 4.36
Challenges in the development of an HIV-1 vaccine. Nature (2008) 4.32
Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A (2006) 4.23
Evidence for positive epistasis in HIV-1. Science (2004) 4.12
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med (2010) 3.53
Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med (2001) 3.37
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol (2004) 3.23
How to make evolution-proof insecticides for malaria control. PLoS Biol (2009) 3.03
Impact of virus infection on host cell protein synthesis. Annu Rev Biochem (1987) 2.98
Reduction of HIV concentration during acute infection: independence from a specific immune response. Science (1996) 2.98
Role of the DIS hairpin in replication of human immunodeficiency virus type 1. J Virol (1996) 2.87
Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J Virol (1997) 2.86
The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface (2009) 2.68
Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci U S A (2000) 2.61
Genetic therapies against HIV. Nat Biotechnol (2007) 2.50
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature (1993) 2.45
Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science (2006) 2.43
Stochastic tunnels in evolutionary dynamics. Genetics (2004) 2.42
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog (2009) 2.36
Pre-existence and emergence of drug resistance in HIV-1 infection. Proc Biol Sci (1997) 2.15
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther (2008) 2.14
Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell (1984) 2.13
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog (2010) 1.99
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A (2011) 1.93
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection. J Virol (2002) 1.84
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther (2004) 1.80
The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS (1990) 1.72
The rate at which asexual populations cross fitness valleys. Theor Popul Biol (2009) 1.71
Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol (2004) 1.61
Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J Virol (2007) 1.60
Dynamics of immune escape during HIV/SIV infection. PLoS Comput Biol (2008) 1.54
Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by site-directed mutagenesis studies. Philos Trans R Soc Lond B Biol Sci (2010) 1.53
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog (2010) 1.48
Defective interfering viruses and their potential as antiviral agents. Rev Med Virol (2010) 1.44
Dynamics of immune escape in HIV infection. Wien Klin Wochenschr (1999) 1.40
Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J Virol (2003) 1.34
A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread. Proc Natl Acad Sci U S A (1996) 1.27
Defective interfering viral particles in acute dengue infections. PLoS One (2011) 1.25
Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci U S A (1994) 1.24
Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression. Mol Ther (2008) 1.23
Multiple infections, immune dynamics, and the evolution of virulence. Am Nat (2008) 1.22
Optimizing within-host viral fitness: infected cell lifespan and virion production rate. J Theor Biol (2004) 1.18
Natural selection and dynamical coexistence of defective and complementing virus segments. J Theor Biol (1992) 1.15
Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci U S A (1994) 1.12
Population dynamics of an RNA virus and its defective interfering particles in passage cultures. Virol J (2010) 1.12
Autonomous targeting of infectious superspreaders using engineered transmissible therapies. PLoS Comput Biol (2011) 1.10
The effect of treatment on pathogen virulence. J Theor Biol (2004) 1.06
Effect of antigen-processing efficiency on in vivo T cell response magnitudes. J Immunol (1998) 1.03
Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes. J Mol Biol (2006) 1.00
Co-operation and defection: playing the field in virus dynamics. J Theor Biol (1993) 1.00
Modeling within-host evolution of HIV: mutation, competition and strain replacement. Bull Math Biol (2007) 0.98
Co-evolution of a filamentous bacteriophage and its defective interfering particles. J Mol Biol (1983) 0.97
Multiple-hit inhibition of infection by defective interfering particles. J Gen Virol (2009) 0.96
Modeling defective interfering virus therapy for AIDS: conditions for DIV survival. Math Biosci (1995) 0.94
HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med (2006) 0.93
Optimal viral production. Bull Math Biol (2003) 0.90
Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivity. Antimicrob Agents Chemother (2011) 0.90
Lentiviral vectors for gene therapy of HIV-1 infection. Curr Gene Ther (2002) 0.86
Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles. PLoS Comput Biol (2010) 0.85
Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes. AIDS Patient Care STDS (2002) 0.83
HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death. J Med Virol (2006) 0.82
Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1. Hum Gene Ther (2005) 0.82
Impaired immune evasion in HIV through intracellular delays and multiple infection of cells. Proc Biol Sci (2012) 0.80
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther (2016) 0.76
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Ecology of zoonoses: natural and unnatural histories. Lancet (2012) 2.71
Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (2005) 1.75
Identifying postelimination trends for the introduction and transmissibility of measles in the United States. Am J Epidemiol (2014) 1.69
Environmental predictors and incubation period of AIDS-associated penicillium marneffei infection in Ho Chi Minh City, Vietnam. Clin Infect Dis (2013) 1.57
Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat Rev Microbiol (2010) 1.50
Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput Biol (2013) 1.49
Utility of R0 as a predictor of disease invasion in structured populations. J R Soc Interface (2007) 1.49
Transmission consequences of coinfection: cytokines writ large? Trends Parasitol (2007) 1.29
Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Med (2006) 1.27
Invasion dynamics in spatially heterogeneous environments. Am Nat (2009) 1.11
Autonomous targeting of infectious superspreaders using engineered transmissible therapies. PLoS Comput Biol (2011) 1.10
Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics (2009) 1.07
The effect of treatment on pathogen virulence. J Theor Biol (2004) 1.06
Likelihood ridges and multimodality in population growth rate models. Ecology (2009) 1.06
Using remote sensing to map the risk of human monkeypox virus in the Congo Basin. Ecohealth (2010) 1.00
Dynamics and management of infectious disease in colonizing populations. Ecology (2006) 0.99
Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses. PLoS Pathog (2013) 0.97
Does the early frog catch the worm? Disentangling potential drivers of a parasite age-intensity relationship in tadpoles. Oecologia (2010) 0.93
Multiple scales of selection influence the evolutionary emergence of novel pathogens. Philos Trans R Soc Lond B Biol Sci (2013) 0.92
Inferring patterns of influenza transmission in swine from multiple streams of surveillance data. Proc Biol Sci (2013) 0.90
Impact of HIV on novel therapies for tuberculosis control. AIDS (2008) 0.87
Synthesizing within-host and population-level selective pressures on viral populations: the impact of adaptive immunity on viral immune escape. J R Soc Interface (2010) 0.86
Monitoring linked epidemics: the case of tuberculosis and HIV. PLoS One (2010) 0.83
Influence of viral replication mechanisms on within-host evolutionary dynamics. Evolution (2012) 0.81
Coadaptive stability of interfering particles with HIV-1 when there is an evolutionary conflict. J Virol (2013) 0.81
Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other. Epidemics (2008) 0.80
The effect of immunodeficiency on the evolution of virulence: an experimental test with the rodent malaria Plasmodium chabaudi. Am Nat (2014) 0.78
Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration. J Antimicrob Chemother (2013) 0.78
Evolutionary invasion and escape in the presence of deleterious mutations. PLoS One (2013) 0.78
Intergenerational phenotypic mixing in viral evolution. Evolution (2013) 0.78
Comment on "On the regulation of populations of mammals, birds, fish, and insects" I. Science (2006) 0.77
Minimizing the threat of pandemic emergence from avian influenza in poultry systems. BMC Infect Dis (2013) 0.77
Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa. PLoS One (2013) 0.77
Asymptomatic and chronic carriage of Leptospira interrogans serovar Pomona in California sea lions (Zalophus californianus). Vet Microbiol (2013) 0.76
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus. Emerg Infect Dis (2020) 0.75
Development of a real-time PCR for the detection of pathogenic Leptospira spp. in California sea lions. Dis Aquat Organ (2014) 0.75
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum. Emerg Infect Dis (2020) 0.75